Medpace Holdings (MEDP) Change in Accured Expenses (2015 - 2026)

Medpace Holdings (MEDP) has reported Change in Accured Expenses for 12 consecutive years, with $45.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 27.13% year-over-year to $45.0 million; the trailing twelve-month figure through Jun 2026 stood at $128.6 million (up 355.6% YoY), and the FY2025 full-year result was $97.1 million, up 475.07% from the prior year.
• Change in Accured Expenses climbed to $45.0 million in Q2 2026 per MEDP's latest filing, from -$1.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $45.3 million in Q3 2025 and bottomed at -$23.2 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged $16.2 million across 5 years, with a median of $20.7 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses slumped 156.48% in 2023, then soared 1241.54% in 2025.
• Over 5 years, Change in Accured Expenses stood at $4.6 million in 2022, then surged by 486.8% to $27.2 million in 2023, then plunged by 89.14% to $2.9 million in 2024, then jumped by 1241.54% to $39.6 million in 2025, then increased by 13.79% to $45.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $45.0 million, -$1.3 million, and $39.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.